The mTOR homeostatic window in kidney disease
Frontiers in Nephrology · 18.11.2026 · 6
DOI: 10.3389/fneph.2026.2008149 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Nephrology, online erschienen am 18.11.2026. Verfasst von Kui Fan und 5 weiteren Autor:innen. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Mechanistic target of rapamycin (mTOR) signaling is both essential for renal cellular homeostasis and a driver of pathological remodeling when persistently activated. This paradox is especially evident in podocytes, where excessive mTOR complex 1 (mTORC1) activity promotes hypertrophy, metabolic stress, proteinuria, and fibrosis, whereas excessive suppression can destabilize the filtration barrier.
Methods
We review cell- and context-specific functions of mTORC1 and mTOR complex 2 (mTORC2) across kidney disease, including podocytopathies, chronic kidney disease, acute kidney injury-to-chronic kidney disease transition, and transplantation.
Results
We propose that the therapeutic objective should shift from global mTOR inhibition toward precision modulation defined by cell identity, molecular complex, dose, disease stage, and duration. Podocyte-targeted everolimus delivery provides preclinical support that spatial restriction can reshape pathway effects and raises the hypothesis that it could widen the therapeutic window.
Discussion
This homeostatic window theory may guide safer antifibrotic and glomerular therapies.
Zitieren
APA
Fan, K., Zhou, Q., Zhou, L., Yu, Y., Zeng, L., & Tang, M. (2026). The mTOR homeostatic window in kidney disease. Frontiers in Nephrology, 6. https://doi.org/10.3389/fneph.2026.2008149
Vancouver
Fan K, Zhou Q, Zhou L, Yu Y, Zeng L, Tang M. The mTOR homeostatic window in kidney disease. Frontiers in Nephrology. 2026;6. doi:10.3389/fneph.2026.2008149
BibTeX
@article{Fan2026,
author = {Fan, Kui and Zhou, Qin and Zhou, Lanxing and Yu, Yuan and Zeng, Li and Tang, Maozhi},
title = {The mTOR homeostatic window in kidney disease},
journal = {Frontiers in Nephrology},
year = {2026},
volume = {6},
doi = {10.3389/fneph.2026.2008149}
}
EUVIMED